Akonni Biosystems to Present at the 2010 OneMedForum on Tuesday, January 12, 2010
FREDERICK, MD. – January 5, 2010 – Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced that Charles Daitch, Ph.D., CEO of Akonni Biosystems, will be presenting at the 2010 OneMedForumconference at the St. Francis Drake Hotel in San Francisco, CA on January 12, 2010. He will be speaking in the Private Companies track at 4:15 pm in Room 313/Mezzanine Level, with a 40‐minute break out session immediately following.
About Akonni Biosystems
Akonni Biosystems was founded in 2003 and has over 20 patents issued with 13 others pending. The company’s core technology is based on work developed at Argonne National Laboratory and the Engelhardt Institute of Molecular Biology and utilizes geldrop array technologies optimized for developing medical applications. Supported by a series of government grants and contracts from NIH, CDC, DOE, DOD, NIJ, and NSF, the company has significantly advanced the original technology by improving the system’s capabilities from sample preparation to final result. Products in its near‐term pipeline include multiplex panel assays for detecting multidrug‐resistant tuberculosis, upper respiratory infections, encephalitis, and hospital‐acquired infections.
Akonni products are currently for research use only. Not for use in diagnostic procedures.
TruDiagnosis Systems, TruDx Readers, TruArray Tests, TruTip Kits, Primers, Lysis and Binding Buffers, Wash Buffers and Elution Buffers: For Research Use Only. Not for use in diagnostic procedures. No claim or representation is intended to provide information for the diagnosis, prevention or treatment of a disease.